These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 33542188)
21. KITENIN promotes glioma invasiveness and progression, associated with the induction of EMT and stemness markers. Lee KH; Ahn EJ; Oh SJ; Kim O; Joo YE; Bae JA; Yoon S; Ryu HH; Jung S; Kim KK; Lee JH; Moon KS Oncotarget; 2015 Feb; 6(5):3240-53. PubMed ID: 25605251 [TBL] [Abstract][Full Text] [Related]
22. miR-504 suppresses mesenchymal phenotype of glioblastoma by directly targeting the FZD7-mediated Wnt-β-catenin pathway. Liu Q; Guan Y; Li Z; Wang Y; Liu Y; Cui R; Wang Y J Exp Clin Cancer Res; 2019 Aug; 38(1):358. PubMed ID: 31419987 [TBL] [Abstract][Full Text] [Related]
23. MiR-491 functions as a tumor suppressor through Wnt3a/β-catenin signaling in the development of glioma. Meng Y; Shang FR; Zhu YL Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10899-10907. PubMed ID: 31858558 [TBL] [Abstract][Full Text] [Related]
24. Targeting the Nuclear Cathepsin L CCAAT Displacement Protein/Cut Homeobox Transcription Factor-Epithelial Mesenchymal Transition Pathway in Prostate and Breast Cancer Cells with the Z-FY-CHO Inhibitor. Burton LJ; Dougan J; Jones J; Smith BN; Randle D; Henderson V; Odero-Marah VA Mol Cell Biol; 2017 Mar; 37(5):. PubMed ID: 27956696 [TBL] [Abstract][Full Text] [Related]
25. Deubiquitinase USP9X deubiquitinates β-catenin and promotes high grade glioma cell growth. Yang B; Zhang S; Wang Z; Yang C; Ouyang W; Zhou F; Zhou Y; Xie C Oncotarget; 2016 Nov; 7(48):79515-79525. PubMed ID: 27783990 [TBL] [Abstract][Full Text] [Related]
26. Knockdown of HOXC6 inhibits glioma cell proliferation and induces cell cycle arrest by targeting WIF-1 in vitro and vivo. Yan TF; Wu MJ; Xiao B; Hu Q; Fan YH; Zhu XG Pathol Res Pract; 2018 Nov; 214(11):1818-1824. PubMed ID: 30228024 [TBL] [Abstract][Full Text] [Related]
28. β-catenin/TCF4 complex induces the epithelial-to-mesenchymal transition (EMT)-activator ZEB1 to regulate tumor invasiveness. Sánchez-Tilló E; de Barrios O; Siles L; Cuatrecasas M; Castells A; Postigo A Proc Natl Acad Sci U S A; 2011 Nov; 108(48):19204-9. PubMed ID: 22080605 [TBL] [Abstract][Full Text] [Related]
29. Hypoxia induced ferritin light chain (FTL) promoted epithelia mesenchymal transition and chemoresistance of glioma. Liu J; Gao L; Zhan N; Xu P; Yang J; Yuan F; Xu Y; Cai Q; Geng R; Chen Q J Exp Clin Cancer Res; 2020 Jul; 39(1):137. PubMed ID: 32677981 [TBL] [Abstract][Full Text] [Related]
30. HOXB7 promotes proliferation and metastasis of glioma by regulating the Wnt/β-catenin pathway. Huo XY; Zhang XY; Yuan F; Zhao XY; You BA Eur Rev Med Pharmacol Sci; 2019 Mar; 23(6):2476-2485. PubMed ID: 30964174 [TBL] [Abstract][Full Text] [Related]
31. Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR-499a-5p/LMX1A/NLRC5 pathway. Zong Z; Song Y; Xue Y; Ruan X; Liu X; Yang C; Zheng J; Cao S; Li Z; Liu Y J Cell Mol Med; 2019 Aug; 23(8):5048-5062. PubMed ID: 31207033 [TBL] [Abstract][Full Text] [Related]
32. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients. Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566 [TBL] [Abstract][Full Text] [Related]
33. PRMT6-mediated transcriptional activation of ythdf2 promotes glioblastoma migration, invasion, and emt via the wnt-β-catenin pathway. Yu P; Xu T; Ma W; Fang X; Bao Y; Xu C; Huang J; Sun Y; Li G J Exp Clin Cancer Res; 2024 Apr; 43(1):116. PubMed ID: 38637831 [TBL] [Abstract][Full Text] [Related]
34. VHL regulates the effects of miR-23b on glioma survival and invasion via suppression of HIF-1α/VEGF and β-catenin/Tcf-4 signaling. Chen L; Han L; Zhang K; Shi Z; Zhang J; Zhang A; Wang Y; Song Y; Li Y; Jiang T; Pu P; Jiang C; Kang C Neuro Oncol; 2012 Aug; 14(8):1026-36. PubMed ID: 22649212 [TBL] [Abstract][Full Text] [Related]
35. AKT/GSK-3β/β-catenin signaling pathway participates in erythropoietin-promoted glioma proliferation. Tang Z; Yang G; Wang X; Chen F; Liao Z; Zhang Z; Liu Z; Zeng W; Fang M; Wang W; Sun X; Huo G J Neurooncol; 2020 Sep; 149(2):231-242. PubMed ID: 32909117 [TBL] [Abstract][Full Text] [Related]
36. HEG1 indicates poor prognosis and promotes hepatocellular carcinoma invasion, metastasis, and EMT by activating Wnt/β-catenin signaling. Zhao YR; Wang JL; Xu C; Li YM; Sun B; Yang LY Clin Sci (Lond); 2019 Jul; 133(14):1645-1662. PubMed ID: 31278131 [TBL] [Abstract][Full Text] [Related]
37. Downregulated microRNA-200a promotes EMT and tumor growth through the wnt/β-catenin pathway by targeting the E-cadherin repressors ZEB1/ZEB2 in gastric adenocarcinoma. Cong N; Du P; Zhang A; Shen F; Su J; Pu P; Wang T; Zjang J; Kang C; Zhang Q Oncol Rep; 2013 Apr; 29(4):1579-87. PubMed ID: 23381389 [TBL] [Abstract][Full Text] [Related]
38. Silencing of microRNA-708 promotes cell growth and epithelial-to-mesenchymal transition by activating the SPHK2/AKT/β-catenin pathway in glioma. Chen Y; Deng X; Chen W; Shi P; Lian M; Wang H; Wang K; Qian D; Xiao D; Long H Cell Death Dis; 2019 Jun; 10(6):448. PubMed ID: 31171769 [TBL] [Abstract][Full Text] [Related]
39. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer. Ma K; Fan Y; Dong X; Dong D; Guo Y; Wei X; Ning J; Geng Q; Wang C; Hu Y; Li M; Niu W; Li E; Wu Y Oncotarget; 2017 Jun; 8(24):38825-38840. PubMed ID: 28418915 [TBL] [Abstract][Full Text] [Related]
40. SHP-2-upregulated ZEB1 is important for PDGFRα-driven glioma epithelial-mesenchymal transition and invasion in mice and humans. Zhang L; Zhang W; Li Y; Alvarez A; Li Z; Wang Y; Song L; Lv D; Nakano I; Hu B; Cheng SY; Feng H Oncogene; 2016 Oct; 35(43):5641-5652. PubMed ID: 27041571 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]